Related Experiment Videos

Advances in nasopharyngeal carcinoma-"West meets East"

Melvin Lk Chua^1,2, Ying Sun^3,4, Stéphane Supiot^5,6

¹Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre Singapore, Singapore.

The British Journal of Radiology

|September 19, 2019

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

General technical considerations on reirradiation and focus on brain and head and neck tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026

High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial.

The Lancet. Oncology·2026

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.

European urology·2026

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026

Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer.

European urology oncology·2026

OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

See all related articles